Abstract

For several decades, p53 has been detected in cancer biopsies by virtue of its high protein expression level which is considered indicative of mutation. Surprisingly, however, mouse genetic studies revealed that mutant p53 is inherently labile, similar to its wild type (wt) counterpart. Consistently, in response to stress conditions, both wt and mutant p53 accumulate in cells. While wt p53 returns to basal level following recovery from stress, mutant p53 remains stable. In part, this can be explained in mutant p53-expressing cells by the lack of an auto-regulatory loop with Mdm2 and other negative regulators, which are pivotal for wt p53 regulation. Further, additional protective mechanisms are acquired by mutant p53, largely mediated by the co-chaperones and their paralogs, the stress-induced heat shock proteins. Consequently, mutant p53 is accumulated in cancer cells in response to chronic stress and this accumulation is critical for its oncogenic gain of functions (GOF). Building on the extensive knowledge regarding wt p53, the regulation of mutant p53 is unraveling. In this review, we describe the current understanding on the major levels at which mutant p53 is regulated. These include the regulation of p53 protein levels by microRNA and by enzymes controlling p53 proteasomal degradation.

Highlights

  • Wild type p53 is a tumor suppressor, which plays a key role in the cellular stress response

  • Specific than proteasomal degradation, it has been observed that ubiquitinated proteins are targeted for lysosomal degradation and could play a major role in regulating mutant p53 [47]

  • Mutant p53 is recognized as a misfolded protein by the heat shock protein chaperons

Read more

Summary

Introduction

Wild type (wt) p53 is a tumor suppressor, which plays a key role in the cellular stress response. The E3 ubiquitin ligase Mdm2, which is the major negative regulator of p53 [reviewed in Ref. Mdm4 ( known as MdmX), which is an Mdm2-related protein, is another key inhibitor of p53 transcriptional activity [16, 17] and is targeted by miRNAs (Figure 1).

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.